1. Home
  2. ABLV vs PRPO Comparison

ABLV vs PRPO Comparison

Compare ABLV & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ABLV

Able View Global Inc.

HOLD

Current Price

$0.74

Market Cap

39.5M

Sector

N/A

ML Signal

HOLD

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$24.80

Market Cap

32.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ABLV
PRPO
Founded
2015
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
39.5M
32.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ABLV
PRPO
Price
$0.74
$24.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.6K
8.7K
Earning Date
09-30-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$114,319,869.00
$22,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.66
N/A
Revenue Growth
N/A
30.95
52 Week Low
$0.59
$3.90
52 Week High
$1.77
$28.50

Technical Indicators

Market Signals
Indicator
ABLV
PRPO
Relative Strength Index (RSI) 56.53 52.79
Support Level $0.65 $23.77
Resistance Level $0.77 $25.64
Average True Range (ATR) 0.07 1.47
MACD 0.01 0.01
Stochastic Oscillator 64.29 28.79

Price Performance

Historical Comparison
ABLV
PRPO

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: